Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C17H19N.C6H12O7 |
Molecular Weight | 433.4947 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.CCC(CN)=C(C1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=HXSORIGWWKXLDZ-IFWQJVLJSA-N
InChI=1S/C17H19N.C6H12O7/c1-2-14(13-18)17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;7-1-2(8)3(9)4(10)5(11)6(12)13/h3-12H,2,13,18H2,1H3;2-5,7-11H,1H2,(H,12,13)/t;2-,3-,4+,5-/m.1/s1
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/14254672
Sources: http://www.ncbi.nlm.nih.gov/pubmed/14254672
Gilutensin is a drug that was developed for the treatment of hypotensive circulatory disorders. As there is no information available on the drug since 1970, its development is supposed to be terminated in early phase.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
44VF23ML3X
Created by
admin on Sat Dec 16 08:07:03 GMT 2023 , Edited by admin on Sat Dec 16 08:07:03 GMT 2023
|
PRIMARY | |||
|
DTXSID20951262
Created by
admin on Sat Dec 16 08:07:03 GMT 2023 , Edited by admin on Sat Dec 16 08:07:03 GMT 2023
|
PRIMARY | |||
|
206726
Created by
admin on Sat Dec 16 08:07:03 GMT 2023 , Edited by admin on Sat Dec 16 08:07:03 GMT 2023
|
PRIMARY | |||
|
28599-37-3
Created by
admin on Sat Dec 16 08:07:03 GMT 2023 , Edited by admin on Sat Dec 16 08:07:03 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD